Fusogenix an Effective Drug Delivery\ Dr. John Lewis's biotechnology company develops next generation nucleic acid medicines and they just announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections. Hear more on what are some of the other advantages of this DNA vaccine even for cancerous cells. Connect with Entos Pharmaceutical: https://www.entospharma.com/ Connect with Dr. John Lewis: https://apcari.ca/meet-the-team/john-d-lewis-research-group/ |
Alberta Impact is proud to partner with Health City in a collaborative effort to shine a light on Alberta lead initiative that are taking the health care industry into the future.